AbbVie inks licensing deal to boost Mavyret access in nearly 100 countries

13th November 2018 Uncategorised 0

AbbVie inked a deal with the Medicines Patent Pool to boost access to hepatitis C drug Mavyret in nearly 100 low- and middle-income countries and territories.

More: AbbVie inks licensing deal to boost Mavyret access in nearly 100 countries
Source: fierce